QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: ICSR Follow-Up and Medical Review

Test your understanding of the concepts covered by GVP Module VI: ICSR Follow-Up and Medical Review.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which combination best illustrates information that may contribute to a causality reassessment?

Database completion date, communication method and case-owner name Temporal relationship, dechallenge, rechallenge, alternative causes and objective findings Reporter nationality, product colour and internal case number Submission format, narrative word count and vendor invoice number

Question 2 of 10 Which statement best describes follow-up prioritisation?

All cases should receive identical follow-up intensity to avoid subjective decisions Priority should reflect the potential clinical and regulatory impact of the missing information Only cases with a positive causality assessment require follow-up Follow-up priority should be based solely on how quickly the reporter responds

Question 3 of 10 What should happen when material new information is obtained after an ICSR has already been submitted?

No action is needed because the original submission cannot be changed The case should be assessed and an updated submission determined under the applicable reporting framework The original submission should be withdrawn in every case The information should be stored only in correspondence records

Question 4 of 10 A follow-up response reveals that an apparently unique report corresponds to another case already in the safety database. What is the appropriate action?

Ignore the new information because duplicate assessment is separate from follow-up Perform duplicate assessment and manage the records under the controlled duplicate process Delete both cases immediately to avoid double counting Treat the report as a new signal without reviewing the source information

Question 5 of 10 Which control is most important when an MAH outsources follow-up activities?

Allow the vendor to define its own criteria without MAH review Define responsibilities, criteria, timelines, escalation, quality oversight, metrics and reconciliation Transfer all accountability to the vendor once the contract is signed Require the vendor to use the same follow-up request for every product and case

Question 6 of 10 An initially vague symptom is later confirmed through diagnostic investigations as a specific medical condition. Which case-management response is most appropriate?

Retain the original vague coding to preserve the initial report unchanged Update the diagnosis and assess whether coded terms, narrative and medical assessment remain consistent Replace the original symptom with the diagnosis without retaining the chronology Treat the diagnostic finding as unrelated unless the reporter submits a new ICSR

Question 7 of 10 Why may pregnancy exposure reports require longitudinal follow-up?

Pregnancy reports can be fully assessed only from the initial maternal exposure date Gestational timing, pregnancy outcome and infant or fetal information may become available later Pregnancy exposure reports are never subject to medical review Follow-up is required only when the mother reports an adverse reaction

Question 8 of 10 A follow-up source confirms that a patient was admitted to hospital because of the reported reaction. What should occur next?

Add the statement to the free-text comments without changing the case assessment Reassess seriousness, update the case as appropriate and determine any regulatory consequences Assume that the medicinal product caused the hospitalisation Delete the original seriousness assessment because it was incomplete

Question 9 of 10 When may a follow-up cycle appropriately be closed despite some desired fields remaining incomplete?

When reasonable attempts have been made, no further information is obtainable and applicable procedures are satisfied When the first communication has been sent, regardless of response Only when every field in the database contains a value When the case is serious, because serious cases cannot be followed up further

Question 10 of 10 Several cases involving the same product contain unusual clinical findings identified during follow-up. What is the most appropriate organisational response?

Keep the information within case processing because signal management begins only with spontaneous initial reports Escalate the information through the signal-management pathway where appropriate Suppress the unusual findings until a confirmed causal relationship exists Close the cases to prevent them from influencing aggregate review

Knowledge Assessment: ICSR Follow-Up and Medical Review

Cookie Settings